Monday, March 07, 2005

Health Canada advises patients about the risks of CRESTOR (rosuvastatin)

From Health Canada:
Health Canada is advising Canadians about important safety information for CRESTOR® (rosuvastatin). A recent US study has found that Asian patients may be at greater risk of developing muscle-related adverse events with this drug. CRESTOR® is a cholesterol-lowering drug in the "statin" family. "Statins" are a specific type of cholesterol-lowering medication.

In Canada, and internationally, CRESTOR® has been associated with reports of a serious condition called rhabdomyolysis. Rhabdomyolysis results in muscle breakdown and the release of muscle cell contents into the bloodstream. ...more

No comments: